The widely used erectile disfunction drug Levitra is now the second drug in its class found to protect the heart against tissue damage following acute heart attack, according to a new study. The findings further support the concept that the novel class of phosphodiesterase-5 inhibitors, or PDE-5 inhibitors, including Levitra and Viagra, may have a new utility in cardiac protection, in addition to their well-known use for the management of erectile dysfunction in men.

In the study, it has been demonstrated for the first time that pretreatment with a clinically relevant dose of Levitra, generically known as vardenafil, induces a protective effect against heart attack injury by opening the mitochondrial KATP channel in an animal model. Levitra like Viagra stabilizes the mitochondria and protects against damage of the heart by opening the mitochondrial KATP channels in cardiac cells.

To read more, visit…..
http://www.news-medical.net/?id=15923